Cargando…
Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology
INTRODUCTION: The purpose of this study was to determine the objective characteristics of orthopaedic musculoskeletal oncology fellowship directors (FDs) by concentrating on the demographics, academic background, institutional history, research experience, and professional affiliations of these lead...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191358/ https://www.ncbi.nlm.nih.gov/pubmed/35696309 http://dx.doi.org/10.5435/JAAOSGlobal-D-22-00039 |
_version_ | 1784725994579427328 |
---|---|
author | Moore, M. Lane Elahi, Muhammad Ali Doan, Matthew K. Pollock, Jordan R. Makovicka, Justin L. Hassebrock, Jeffrey D. Brinkman, Joseph C. Patel, Karan A. |
author_facet | Moore, M. Lane Elahi, Muhammad Ali Doan, Matthew K. Pollock, Jordan R. Makovicka, Justin L. Hassebrock, Jeffrey D. Brinkman, Joseph C. Patel, Karan A. |
author_sort | Moore, M. Lane |
collection | PubMed |
description | INTRODUCTION: The purpose of this study was to determine the objective characteristics of orthopaedic musculoskeletal oncology fellowship directors (FDs) by concentrating on the demographics, academic background, institutional history, research experience, and professional affiliations of these leaders. METHODS: Data were collected for each FD through institutional biographies or publicly available curriculum vitae. The data collected for each FD included demographic, professional, and research information. RESULTS: Of the 19 FDs, 15 (78.9%) were male, and 4 (21.1%) were female. The mean age for all FDs was 49.2 ± 9.1 years. Most FDs were White (n = 16; 84.2%). The mean Scopus H-index, total number of citations, and total number of publications among all 19 FDs were 21.6 ± 13.8, 2,290.6 ± 2,709.0, and 84.0 ± 54.7, respectively. The mean number of years serving in the FD role was 7.1 ± 9.1 years, and the mean number of years that the FD was employed at his/her current institution was 11.1 ± 8.1 years. CONCLUSION: This study shows that orthopaedic musculoskeletal oncology FDs were mainly White (84.2%), male (78.9%), and in their late 40s; have filled their role as FD for an average of 7.1 years; and are very productive in research. |
format | Online Article Text |
id | pubmed-9191358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-91913582022-06-13 Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology Moore, M. Lane Elahi, Muhammad Ali Doan, Matthew K. Pollock, Jordan R. Makovicka, Justin L. Hassebrock, Jeffrey D. Brinkman, Joseph C. Patel, Karan A. J Am Acad Orthop Surg Glob Res Rev Research Article INTRODUCTION: The purpose of this study was to determine the objective characteristics of orthopaedic musculoskeletal oncology fellowship directors (FDs) by concentrating on the demographics, academic background, institutional history, research experience, and professional affiliations of these leaders. METHODS: Data were collected for each FD through institutional biographies or publicly available curriculum vitae. The data collected for each FD included demographic, professional, and research information. RESULTS: Of the 19 FDs, 15 (78.9%) were male, and 4 (21.1%) were female. The mean age for all FDs was 49.2 ± 9.1 years. Most FDs were White (n = 16; 84.2%). The mean Scopus H-index, total number of citations, and total number of publications among all 19 FDs were 21.6 ± 13.8, 2,290.6 ± 2,709.0, and 84.0 ± 54.7, respectively. The mean number of years serving in the FD role was 7.1 ± 9.1 years, and the mean number of years that the FD was employed at his/her current institution was 11.1 ± 8.1 years. CONCLUSION: This study shows that orthopaedic musculoskeletal oncology FDs were mainly White (84.2%), male (78.9%), and in their late 40s; have filled their role as FD for an average of 7.1 years; and are very productive in research. Wolters Kluwer 2022-06-10 /pmc/articles/PMC9191358/ /pubmed/35696309 http://dx.doi.org/10.5435/JAAOSGlobal-D-22-00039 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Moore, M. Lane Elahi, Muhammad Ali Doan, Matthew K. Pollock, Jordan R. Makovicka, Justin L. Hassebrock, Jeffrey D. Brinkman, Joseph C. Patel, Karan A. Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology |
title | Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology |
title_full | Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology |
title_fullStr | Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology |
title_full_unstemmed | Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology |
title_short | Investigation of Fellowship Leadership in Orthopaedic Musculoskeletal Oncology |
title_sort | investigation of fellowship leadership in orthopaedic musculoskeletal oncology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191358/ https://www.ncbi.nlm.nih.gov/pubmed/35696309 http://dx.doi.org/10.5435/JAAOSGlobal-D-22-00039 |
work_keys_str_mv | AT mooremlane investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT elahimuhammadali investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT doanmatthewk investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT pollockjordanr investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT makovickajustinl investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT hassebrockjeffreyd investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT brinkmanjosephc investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology AT patelkarana investigationoffellowshipleadershipinorthopaedicmusculoskeletaloncology |